These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 24106105)
1. HA-coated chitosan nanoparticles for CD44-mediated nucleic acid delivery. Almalik A; Day PJ; Tirelli N Macromol Biosci; 2013 Dec; 13(12):1671-80. PubMed ID: 24106105 [TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid-coated chitosan nanoparticles: molecular weight-dependent effects on morphology and hyaluronic acid presentation. Almalik A; Donno R; Cadman CJ; Cellesi F; Day PJ; Tirelli N J Control Release; 2013 Dec; 172(3):1142-50. PubMed ID: 24103813 [TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid (HA) presentation as a tool to modulate and control the receptor-mediated uptake of HA-coated nanoparticles. Almalik A; Karimi S; Ouasti S; Donno R; Wandrey C; Day PJ; Tirelli N Biomaterials; 2013 Jul; 34(21):5369-80. PubMed ID: 23615561 [TBL] [Abstract][Full Text] [Related]
5. Nanocarriers for cytoplasmic delivery: cellular uptake and intracellular fate of chitosan and hyaluronic acid-coated chitosan nanoparticles in a phagocytic cell model. Zaki NM; Nasti A; Tirelli N Macromol Biosci; 2011 Dec; 11(12):1747-60. PubMed ID: 21954171 [TBL] [Abstract][Full Text] [Related]
6. Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis. Lu HD; Zhao HQ; Wang K; Lv LL Int J Pharm; 2011 Nov; 420(2):358-65. PubMed ID: 21911044 [TBL] [Abstract][Full Text] [Related]
7. Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response. Mizrahy S; Raz SR; Hasgaard M; Liu H; Soffer-Tsur N; Cohen K; Dvash R; Landsman-Milo D; Bremer MG; Moghimi SM; Peer D J Control Release; 2011 Dec; 156(2):231-8. PubMed ID: 21745506 [TBL] [Abstract][Full Text] [Related]
8. Chitosan-hyaluronic acid nanoparticles for gene silencing: the role of hyaluronic acid on the nanoparticles' formation and activity. Al-Qadi S; Alatorre-Meda M; Zaghloul EM; Taboada P; Remunán-López C Colloids Surf B Biointerfaces; 2013 Mar; 103():615-23. PubMed ID: 23274155 [TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44. Wang T; Hou J; Su C; Zhao L; Shi Y J Nanobiotechnology; 2017 Jan; 15(1):7. PubMed ID: 28068992 [TBL] [Abstract][Full Text] [Related]
13. Tumor-specific delivery of siRNA using supramolecular assembly of hyaluronic acid nanoparticles and 2b RNA-binding protein/siRNA complexes. Choi KM; Jang M; Kim JH; Ahn HJ Biomaterials; 2014 Aug; 35(25):7121-32. PubMed ID: 24854094 [TBL] [Abstract][Full Text] [Related]
14. Self-assembled nanoparticles based on amphiphilic chitosan derivative and hyaluronic acid for gene delivery. Liu Y; Kong M; Cheng XJ; Wang QQ; Jiang LM; Chen XG Carbohydr Polym; 2013 Apr; 94(1):309-16. PubMed ID: 23544543 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo gene delivery using chitosan/hyaluronic acid nanoparticles: Influences of molecular mass of hyaluronic acid and lyophilization on transfection efficiency. Sato T; Nakata M; Yang Z; Torizuka Y; Kishimoto S; Ishihara M J Gene Med; 2017 Aug; 19(8):. PubMed ID: 28667693 [TBL] [Abstract][Full Text] [Related]
16. Chitosan/Hyaluronic Acid Nanoparticles: Rational Design Revisited for RNA Delivery. Lallana E; Rios de la Rosa JM; Tirella A; Pelliccia M; Gennari A; Stratford IJ; Puri S; Ashford M; Tirelli N Mol Pharm; 2017 Jul; 14(7):2422-2436. PubMed ID: 28597662 [TBL] [Abstract][Full Text] [Related]
17. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles. Cadete A; Figueiredo L; Lopes R; Calado CC; Almeida AJ; Gonçalves LM Eur J Pharm Sci; 2012 Mar; 45(4):451-8. PubMed ID: 21986445 [TBL] [Abstract][Full Text] [Related]
18. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer. Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852 [TBL] [Abstract][Full Text] [Related]
19. Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy. de la Fuente M; Seijo B; Alonso MJ Invest Ophthalmol Vis Sci; 2008 May; 49(5):2016-24. PubMed ID: 18436835 [TBL] [Abstract][Full Text] [Related]
20. Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery. Ping Y; Liu C; Zhang Z; Liu KL; Chen J; Li J Biomaterials; 2011 Nov; 32(32):8328-41. PubMed ID: 21840593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]